Codes ATC:
A04AA01
EMLc
Indication
Palliative care
Code ICD11:
QC7A
INN
Ondansetron
Type de médicament
Chemical agent
Type de liste
Liste de base
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
2 mg per mL in 2 mL ampoule (as hydrochloride dihydrate) ;
2 mg per mL in 4 mL ampoule (as hydrochloride dihydrate)
Oral > Liquid: 4 mg per 5 mL (as hydrochloride dihydrate)
Oral > Solid: 4 mg (as hydrochloride dihydrate) ; 8 mg (as hydrochloride dihydrate)
Oral > Liquid: 4 mg per 5 mL (as hydrochloride dihydrate)
Oral > Solid: 4 mg (as hydrochloride dihydrate) ; 8 mg (as hydrochloride dihydrate)
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Wikipédia
DrugBank
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of ondansetron injection 2 mg/mL in 4 mL ampoule to the EML and EMLc;
- to modify the formulation descriptions to consistently describe the available dosage forms.